British Gynaecological Cancer Society

What British Gynaecological Cancer Society does

The British Gynaecological Cancer Society (BGCS) is a UK-registered charity (Charity number 290959) and the national professional society dedicated to gynaecological oncology. Its stated mission is to advance the science and art of gynaecological oncology for the benefit of the public, with primary audiences comprising consultant gynaecological oncologists, subspecialty and specialty trainees, clinical nurse specialists, and allied health professionals across the UK. Secondary audiences include patients and the public seeking reliable information, plus NHS and academic institutions participating in audit and improvement programmes.

BGCS's core offerings span clinical guidelines and consensus documents (the first national Ovarian and Endometrial Cancer Guidelines, the Sentinel Consensus Document for vulval, endometrial, and cervical cancer developed through a Delphi process), training programmes (subspecialty training, cadaveric and surgical skills courses, the Basingstoke cytoreductive surgery training opportunity), a flagship Annual Scientific Meeting rotating across UK cities, a podcast series, and an awards and grants programme (Nurse and Allied Health Practitioner Travelling Fellowships at £1,000, Surgical Travelling Fellowships, Kickstarter Grants up to £7,500, plus trainee and medical student prizes). These are delivered through a WordPress-based website (bgcs.org.uk), email newsletters, and social media, with no proprietary software platform or API.

The society operates as a non-profit, funded by membership subscriptions from healthcare professionals, event registration fees (e.g., Autumn Meeting rates ranged from £75 for trainees/nurses to £120 for consultants), and industry sponsorships from pharmaceutical and medical device companies. The organisation is run by an elected volunteer Council (President, Vice President, Honorary Secretary, Honorary Treasurer, plus regional and specialty representatives) with one part-time administrative assistant as the only paid operational staff. BGCS is governed by trustees and operates autonomously with no parent company or external ownership, deriving its strategic mandate from member consensus and partnership with bodies such as RCOG, BSGE, HQIP, Ovarian Cancer Action, Target Ovarian Cancer, and the World Ovarian Cancer Coalition.

Name

British Gynaecological Cancer Society

Legal name

British Gynaecological Cancer Society

Website

https://bgcs.org.uk

Company type

Private

Operating status

Operating

Headcount range

1–10 employees

Ownership category

akta.pro rank

Product category

Professional Medical Society Services

NAICS

Voluntary Health Organizations (813212)

SIC

Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)

akta.pro industry

PRIMARYHLAKAJAD

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Obstetrics & Gynecology (OB/GYN)

SECONDARYHLAFAJAK

Gynecologic Oncology & Women’s Cancer Centers

Healthcare & Life Sciences/Healthcare Providers & Systems/Women’s & Children’s Health Providers

SECONDARYHLAKAFAF

Gynecologic Oncology

Healthcare & Life Sciences/Specialist Medical Practice/Hematology & Oncology

Keywords

• Gynaecological oncology guidelines
• Professional medical society
• Clinical cancer training
• Annual scientific meeting
• Cancer research grants

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others, Technology or R&D

Revenue model

1. Membership fees: The society offers membership to healthcare professionals including consultants, trainees, nurses, and allied health professionals. Membership provides access to guidelines, training, grants, awards, and the professional network.
2. Event registration fees: The BGCS charges registration fees for its Annual Scientific Meeting, training courses, and other educational events. Fee structure varies by attendee type (consultant, trainee, nurse, industry).
3. Industry sponsorships and exhibitions: Industry partners sponsor BGCS events, symposia, and meetings. Sponsors include pharmaceutical companies and medical device manufacturers.

Pricing tiers

Go-to-market motion2 records

Distribution channels3 records

Marketing channels5 records

Core offering

The British Gynaecological Cancer Society is a UK professional medical society that develops and publishes national clinical guidelines and consensus documents for gynaecological cancers, runs an Annual Scientific Meeting and training programmes, awards research grants, travelling fellowships and prizes, and provides a member resource library, podcast series and patient information materials for healthcare professionals in gynaecological oncology.

Product overview

The British Gynaecological Cancer Society (BGCS) is a professional medical society, not a software product company. Its offerings consist of clinical guidelines and consensus documents (Ovarian and Endometrial Cancer Guidelines, Sentinel Consensus Documents), professional development programs (Annual Scientific Meeting, training courses, awards and grants), educational resources (podcast series, resource library), and patient information materials. These are delivered through its website as informational and membership services rather than a unified software platform.

Differentiator

Problem solved

Functional benefit

Products and services

• Ovarian and Endometrial Cancer Guidelines
• Sentinel Consensus Document for Vulval, Endometrial and Cervical Cancer
• BGCS COVID-19 Framework and Resources
• Annual Scientific Meeting
• Awards, Grants, Prizes and Fellowships Program
• Gynaecological Oncology Training Programs
• Podcast Series
• Resource Library
• Patient Information Resources

Quantifiable outcome

• Awarded £75,000 in COVID-19 research grants to support gynaecological cancer care research

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Eight partnerships are on record, tiered core and minor.

• Ovarian Cancer ActioncoreStrategic or Co-development Partner · 8 March 2022BGCS supports the IMPROVE UK project led by Ovarian Cancer Action, which aims to tackle unfairness in healthcare for women with ovarian cancer across six NHS Cancer Centres in the UK.
• OvacomeminorStrategic or Co-development Partner · 8 March 2022Ovarian cancer patient support charity that is part of the support network for the IMPROVE UK project.
• Target Ovarian CancercoreStrategic or Co-development Partner · 14 June 2021Joint funding partner for the Ovarian Cancer Audit Feasibility Pilot, which has now been commissioned by HQIP as a permanent national audit.
• Healthcare Quality Improvement Partnership (HQIP)coreStrategic or Co-development Partner · 14 June 2021Commissioning body for the national ovarian cancer audit, taking forward the model established by the BGCS-led feasibility pilot.
• The Eve AppealminorStrategic or Co-development Partner · 1 May 2021BGCS shares information about The Eve Appeal's research grant calls for vulval cancer and gynaecological cancer prevention projects.
• World Ovarian Cancer CoalitioncoreStrategic or Co-development Partner · 14 September 2020BGCS has signed up to support the Ovarian Cancer Charter from the World Ovarian Cancer Coalition through a Memorandum of Understanding (MOU). This partnership supports international collaboration on ovarian cancer awareness and policy.
• RCOG (Royal College of Obstetricians and Gynaecologists)coreStrategic or Co-development Partner · 28 March 2020Joint guidance development for management of abnormal uterine bleeding during COVID-19 pandemic. BGCS works with RCOG on professional standards and guidelines.
• BSGE (British Society for Gynaecological Endoscopy)coreStrategic or Co-development Partner · 28 March 2020Joint guidance development with BGCS and RCOG for management of abnormal uterine bleeding during COVID-19 pandemic.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Royal College of Radiologists (RCR): UK royal college for clinical radiology and clinical oncology. RCR sets standards and training for clinical oncologists who are part of BGCS's multidisciplinary gynaecological oncology audience and collaborates on cancer policy.
• Royal College of Obstetricians and Gynaecologists (RCOG): UK royal college covering the broader obstetrics and gynaecology specialty. BGCS partners with RCOG on joint guidance and overlapping professional standards for gynaecological cancer care within the wider OB/GYN field.

Others

• British Oncology Pharmacy Association (BOPA): UK professional society for oncology pharmacists. BOPA is an adjacent specialist society that operates a similar membership, guidelines, and conference model within UK cancer care, intersecting with BGCS's multidisciplinary audience.
• Association of Cancer Physicians (ACP): UK membership organisation for medical oncologists. ACP overlaps with BGCS's medical oncology and clinical oncology representatives and runs a comparable annual meeting and training programme structure.

Direct peers

• International Gynecologic Cancer Society (IGCS): Global professional society dedicated to gynaecological cancers. IGCS is the international counterpart to BGCS, offering worldwide guidelines, training, and the biennial World Congress that complements BGCS's UK-focused Annual Scientific Meeting.
• Society of Gynecologic Oncology (SGO): US-based professional society for gynaecologic oncologists. SGO serves an analogous role to BGCS in the United States, publishing practice guidelines, hosting an annual meeting, and funding research and training for the same specialty.
• European Society of Gynaecological Oncology (ESGO): European-level professional society for gynaecological oncology. ESGO operates at a supranational tier to BGCS's UK tier, issuing parallel clinical guidelines, training curricula, and congresses for the same specialist audience.
• British Society for Gynaecological Endoscopy (BSGE): UK professional society focused on gynaecological endoscopy. BGCS and BSGE co-developed joint guidance during COVID-19 and address overlapping clinician audiences in benign and oncologic gynaecological surgery.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks4 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/british-gynaecological-cancer-society

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about British Gynaecological Cancer Society